maprotiline has been researched along with Pulmonary Fibrosis in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salmeron, S | 1 |
| Brenot, F | 1 |
| Rain, B | 1 |
| Peuchemaur, M | 1 |
| Herve, P | 1 |
| Simonneau, G | 1 |
| Duroux, P | 1 |
| Rouveix, B | 1 |
1 other study available for maprotiline and Pulmonary Fibrosis
| Article | Year |
|---|---|
Maprotiline and pulmonary alveolitis.
Topics: Aged; Anthracenes; Drug Hypersensitivity; Humans; Male; Maprotiline; Pulmonary Fibrosis | 1988 |